Table of Contents
Metal-Based Drugs
Volume 2009, Article ID 348916, 11 pages
http://dx.doi.org/10.1155/2009/348916
Research Article

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent

1Ludwig Boltzmann Cluster Translational Oncology, Operngasse 6/5, 1010 Vienna, Austria
2Medical University of Vienna, Department of Gynecology, Waehringer Guertel 18-20, 1090 Vienna, Austria
3Institute of Pharmacy, University of Greifswald, Friedrich-Ludwig-Jahn-Strasse 17, 17487 Greifswald, Germany

Received 25 November 2008; Revised 23 February 2009; Accepted 15 April 2009

Academic Editor: Mauro Coluccia

Copyright © 2009 Ulrike Olszewski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Rosenberg, L. van Camp, and T. Krigas, “Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode,” Nature, vol. 205, no. 4972, pp. 698–699, 1965. View at Publisher · View at Google Scholar
  2. T. Boulikas and M. Vougiouka, “Cisplatin and platinum drugs at the molecular level,” Oncology Reports, vol. 10, no. 6, pp. 1663–1682, 2003. View at Google Scholar
  3. C. A. Rabik and M. E. Dolan, “Molecular mechanisms of resistance and toxicity associated with platinating agents,” Cancer Treatment Reviews, vol. 33, no. 1, pp. 9–23, 2007. View at Publisher · View at Google Scholar · View at PubMed
  4. L. Kelland, “The resurgence of platinum-based cancer chemotherapy,” Nature Reviews Cancer, vol. 7, no. 8, pp. 573–584, 2007. View at Publisher · View at Google Scholar · View at PubMed
  5. R. Žaludová, A. Žákovská, J. Kašpárková et al., “DNA interactions of bifunctional dinuclear platinum(II) antitumor agents,” European Journal of Biochemistry, vol. 246, no. 2, pp. 508–517, 1997. View at Publisher · View at Google Scholar
  6. I. Kostova, “Platinum complexes as anticancer agents,” Recent Patents on Anti-Cancer Drug Discovery, vol. 1, no. 1, pp. 1–22, 2006. View at Publisher · View at Google Scholar
  7. K. Ota, “Nedaplatin,” Japanese Journal of Cancer and Chemotherapy, vol. 23, no. 3, pp. 379–387, 1996. View at Google Scholar
  8. R. B. Weiss and M. C. Christian, “New cisplatin analogues in development: a review,” Drugs, vol. 46, no. 3, pp. 360–377, 1993. View at Google Scholar
  9. L. R. Kelland and M. J. McKeage, “New platinum agents. A comparison in ovarian cancer,” Drugs & Aging, vol. 5, no. 2, pp. 85–95, 1994. View at Google Scholar
  10. P. J. Bednarski, F. S. Mackay, and P. J. Sadler, “Photoactivatable platinum complexes,” Anti-Cancer Agents in Medicinal Chemistry, vol. 7, no. 1, pp. 75–93, 2007. View at Publisher · View at Google Scholar
  11. N. P. Farrell, “Preclinical perspectives on the use of platinum compounds in cancer chemotherapy,” Seminars in Oncology, vol. 31, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at PubMed
  12. R. C. Dolman, G. B. Deacon, and T. W. Hambley, “Studies of the binding of a series of platinum(IV) complexes to plasma proteins,” Journal of Inorganic Biochemistry, vol. 88, no. 3-4, pp. 260–267, 2002. View at Publisher · View at Google Scholar
  13. M. D. Hall, R. A. Alderden, M. Zhang et al., “The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours,” Journal of Structural Biology, vol. 155, no. 1, pp. 38–44, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. M. D. Hall, H. R. Mellor, R. Callaghan, and T. W. Hambley, “Basis for design and development of platinum(IV) anticancer complexes,” Journal of Medicinal Chemistry, vol. 50, no. 15, pp. 3403–3411, 2007. View at Publisher · View at Google Scholar · View at PubMed
  15. L. Kelland, “Broadening the clinical use of platinum drug-based chemotherapy with new analogues: satraplatin and picoplatin,” Expert Opinion on Investigational Drugs, vol. 16, no. 7, pp. 1009–1021, 2007. View at Publisher · View at Google Scholar · View at PubMed
  16. H. Choy, C. Park, and M. Yao, “Current status and future prospects for satraplatin, an oral platinum analogue,” Clinical Cancer Research, vol. 14, no. 6, pp. 1633–1638, 2008. View at Publisher · View at Google Scholar · View at PubMed
  17. C. Vetter, C. Wagner, G. N. Kaluderović, R. Paschke, and D. Steinborn, “Synthesis, characterization, and cytotoxicity of trimethylplatinum(IV) complexes with 2-thiocytosine and 1-methyl-2-thiocytosine ligands,” Inorganica Chimica Acta, vol. 362, no. 1, pp. 189–195, 2009. View at Publisher · View at Google Scholar
  18. M. E. Kelly, A. Dietrich, S. Gómez-Ruiz et al., “Platinum(IV) metallacrown ethers: synthesis, structures, host properties and anticancer evaluation,” Organometallics, vol. 27, no. 19, pp. 4917–4927, 2008. View at Publisher · View at Google Scholar
  19. B. B. Krajčinović, G. N. Kaluderović, D. Steinborn et al., “Synthesis and in vitro antitumoral activity of novel O,O-di-2-alkyl-(S,S )-ethylenediamine-N,N-di-2-propanoate ligands and corresponding platinum(II/IV) complexes,” Journal of Inorganic Biochemistry, vol. 102, no. 4, pp. 892–900, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. G. N. Kaluderović, H. Schmidt, S. Schwieger et al., “Platinum(IV) complexes with ethylenediamine-N,N-diacetate diester (R2edda) ligands: synthesis, characterization and in vitro antitumoral activity,” Inorganica Chimica Acta, vol. 361, no. 5, pp. 1395–1404, 2008. View at Publisher · View at Google Scholar
  21. L. Pendyala, J. W. Cowens, G. B. Chheda, S. P. Dutta, and P. J. Creaven, “Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans,” Cancer Research, vol. 48, no. 12, pp. 3533–3536, 1988. View at Google Scholar
  22. O. Novakova, O. Vrana, I. Kiseleva, and V. Brabec, “DNA interactions of antitumour platinum(IV) complexes,” European Journal of Biochemistry, vol. 228, no. 3, pp. 616–624, 1995. View at Publisher · View at Google Scholar
  23. W. K. Anderson, D. A. Quagliato, R. D. Haugwitz, V. L. Narayanan, and M. K. Wolpert-DeFilippes, “Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane,” Cancer Treatment Reports, vol. 70, no. 8, pp. 997–1002, 1986. View at Google Scholar
  24. A. Eastman, “Glutathione-mediated activation of anticancer platinum(IV) complexes,” Biochemical Pharmacology, vol. 36, no. 23, pp. 4177–4178, 1987. View at Publisher · View at Google Scholar
  25. M. D. Hall and T. W. Hambley, “Platinum(IV) antitumour compounds: their bioinorganic chemistry,” Coordination Chemistry Reviews, vol. 232, no. 1-2, pp. 49–67, 2002. View at Publisher · View at Google Scholar
  26. M. A. Presnov, A. L. Konovalova, A. M. Kozlov, V. K. Brovtsyn, and L. F. Romanova, “The antitumor activity of oxoplatinum,” Neoplasma, vol. 32, no. 1, pp. 73–83, 1985. View at Google Scholar
  27. A. L. Konovalova, M. A. Presnov, N. N. Zheligovskaia, and E. M. Treshchalina, “Antitumor effect of complex compounds of tetravalent platinum,” Doklady Akademii Nauk SSSR, vol. 234, no. 1, pp. 223–226, 1977. View at Google Scholar
  28. A. Laznickova, V. Semecky, M. Laznicek, V. Zubr, J. Koksal, and J. Kvetina, “Effect of oxoplatinum and CBDCA on renal functions in rats,” Neoplasma, vol. 36, no. 2, pp. 161–169, 1989. View at Google Scholar
  29. E. A. Lobanova, “Pharmacokinetics of the antitumor drug oxoplatinum labeled with 191Pt,” Meditsinskaya Radiologiya, vol. 30, no. 5, pp. 75–78, 1985. View at Google Scholar
  30. E. A. Lobanova, A. S. Singin, L. K. Moldovanova, and A. S. Mas'ko, “Pharmacokinetic research on oxoplatinum,” Vestnik Akademii meditsinskikh Nauk SSSR, no. 5, pp. 56–61, 1986. View at Google Scholar
  31. E. E. Blatter, J. F. Vollano, B. S. Krishnan, and J. C. Dabrowiak, “Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA,” Biochemistry, vol. 23, no. 21, pp. 4817–4820, 1984. View at Publisher · View at Google Scholar
  32. S. Choi, C. Filotto, M. Bisanzo et al., “Reduction and anticancer activity of platinum(IV) complexes,” Inorganic Chemistry, vol. 37, no. 10, pp. 2500–2504, 1998. View at Publisher · View at Google Scholar
  33. L. T. Ellis, H. M. Er, and T. W. Hambley, “The influence of the axial ligands of a series of platinum(IV) anti-cancer complexes on their reduction to platinum(II) and reaction with DNA,” Australian Journal of Chemistry, vol. 48, no. 4, pp. 793–806, 1995. View at Publisher · View at Google Scholar
  34. R. M. Roat and J. Reedijk, “Reaction of mer-trichloro(diethylenetriamine)platinum(IV) chloride, (mer-[Pt(dien)Cl3]Cl), with purine nucleosides and nucleotides results in formation of platinum(II) as well as platinum(IV) complexes,” Journal of Inorganic Biochemistry, vol. 52, no. 4, pp. 263–274, 1993. View at Publisher · View at Google Scholar
  35. W. M. Scovell, N. Muirhead, and L. R. Kroos, “cis-diamminedichloroplatinum(II) selectively cross-links high mobility group proteins 1 and 2 to DNA in micrococcal nuclease accessible regions of chromatin,” Biochemical and Biophysical Research Communications, vol. 142, no. 3, pp. 826–835, 1987. View at Publisher · View at Google Scholar
  36. J. H. Toney, B. A. Donahue, P. J. Kellett, S. L. Bruhn, J. M. Essigmann, and S. J. Lippard, “Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II),” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 21, pp. 8328–8332, 1989. View at Publisher · View at Google Scholar
  37. E. N. Hughes, B. N. Engelsberg, and P. C. Billings, “Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2,” The Journal of Biological Chemistry, vol. 267, no. 19, pp. 13520–13527, 1992. View at Google Scholar
  38. G. Chu, “Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair,” The Journal of Biological Chemistry, vol. 269, no. 2, pp. 787–790, 1994. View at Google Scholar
  39. N. A. Kratochwil, A. I. Ivanov, M. Patriarca et al., “Surprising reactions of iodo Pt(IV) and Pt(II) complexes with human albumin: detection of Cys34 sulfenic acid,” Journal of the American Chemical Society, vol. 121, no. 36, pp. 8193–8203, 1999. View at Publisher · View at Google Scholar
  40. J. F. Neault and H. A. Tajmir-Riahi, “Interaction of cisplatin with human serum albumin. Drug binding mode and protein secondary structure,” Biochimica et Biophysica Acta, vol. 1384, no. 1, pp. 153–159, 1998. View at Publisher · View at Google Scholar
  41. M. D. Hall, S. Amjadi, M. Zhang, P. J. Beale, and T. W. Hambley, “The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines,” Journal of Inorganic Biochemistry, vol. 98, no. 10, pp. 1614–1624, 2004. View at Publisher · View at Google Scholar · View at PubMed
  42. T. W. Hambley, A. R. Battle, G. B. Deacon et al., “Modifying the properties of platinum(IV) complexes in order to increase biological effectiveness,” Journal of Inorganic Biochemistry, vol. 77, no. 1-2, pp. 3–12, 1999. View at Publisher · View at Google Scholar